首页> 美国政府科技报告 >Relative Contribution of Ornithine Decarboxylase (ODC) Versus S- adenosylmethionine Decarboxylase (SAMDC) to Human Breast Cancer Progression and Development
【24h】

Relative Contribution of Ornithine Decarboxylase (ODC) Versus S- adenosylmethionine Decarboxylase (SAMDC) to Human Breast Cancer Progression and Development

机译:鸟氨酸脱羧酶(ODC)与s-腺苷甲硫氨酸脱羧酶(samDC)对人乳腺癌进展和发展的相对贡献

获取原文

摘要

Although polyamines (PA) play an important role in breast cancer phenotype, the relative contribution of the two PA biosynthetic enzymes, ornithine decarboxylase (ODC) and S- adenosylmethionine decarboxylase (SAMDC) is not known. Our data show that overexpression of SAMDC in MCP-7 breast cancer cells leads to a more benign biologic behavior characterized by decreased invasiveness in vitro and reduced tumorigenicity in nude mice. These effects may be mediated by the compensatory downregulation of ODC leading to reduced cellular putrescine and spermidine contents. In contrast, in experiments conducted in MDA-MB-435 and MDA-MB-231 breast cancer cells, we have observed that ODC adversely affects breast cancer phenotype and, most importantly, contributes to the development of distant metastasis. In the aggregate, our data point to ODC as an attractive target in the adjuvant therapy of breast cancer.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号